Experimental results from the study by Pelzer et al (1) indicated that ATF3 was highly expressed in most prostate cancer cell lines, and that the overexpression of ATF3 induced the proliferation of prostate cancer cells and accelerated cell cycle progression from the G1 to the S phase. Here, ATF3 is linked to prostate carcinoma.